Hyperthermia enhances the cytotoxic effect of some chemotherapeutic agents by various mechanisms (Johnson & Pavelec, 1973; Hahn, 1975) . In a series of experiments studying the effect of cyclophosphamide (CY) at various temperatures, the effect of two or more treatments was investigated. It has been demonstrated that administration of some drugs induces resistance to a subsequent administration of the drug (Schimke, 1984; Goldie & Coldman, 1984) , and that hyperthermia also induces resistance to some chemotherapeutic agents (Morgan et al., 1979; Donaldson et al., 1978) .
Animals were 10 to 12 week old C3Hf/Sed mice derived from our defined flora mouse colony. They were kept in the same facility throughout the duration of the experiments. Sterilized mouse pellets and acidified and vitamin-K fortified water were provided ad libitum. The early generation isotransplants of a fibrosarcoma which arose spontaneously in a C3Hf/Sed mouse, FSa-II were used. Single cell suspensions were prepared by a trypsinization procedure and transplanted into the foot. Hyperthermia was administered by immersing the animals' feet into a water bath where desired temperatures were maintained by a constant temperature circulator (Lauda, model MS, West Germany) (Urano et al., 1980) . Animals were not anaesthetised for hyperthermia treatment.
Tumours were treated when they reached an average diameter of 4mm (35 mm3) and the TG (tumour growth) time, or the time required for a tumour to reach 1000 mm3 after the last treatment day, was determined on the tumourregrowth curve for each tumour. Then, the median TG time was calculated for each group by logit analysis (Urano et al., 1980) . Approximately 7 to 10 animals were used for each datum point and all experiments were repeated at least once.
The test agent was cyclophosphamide (CY) (Mead Johnson, Syracuse, NY). This agent was selected since its plasma half-time is longer in comparison with other alkylating agents (Begg & Smith, 1984) . It was dissolved in distilled water and injected intraperitoneally.
Animals with 4mm FSa-II tumours received one to five daily treatments of CY alone, combined heat and CY, or combined glucose, hyperthermia and CY treatments. A CY dose of 50mgkg-1 each was given i.p. 30min before hyperthermia, and a glucose dose of 5 mg g-1 each was given 60min before heat treatment. Hyperthermia was at 41.5°C for 60min, which gives a maximum enhancement for the CY treatment (Urano et al., 1985) . The rationale for the administration of glucose is given elsewhere (Urano & Kim, 1983) . Our previous experiments indicated that hyperglycaemia enhances the cytotoxic effect of CY as a result of reduced tumour tissue pH (Urano et al., 1985; Rhee et al., unpublished data) .
The dose-response curve for single doses of CY appears to be exponential, while those for combined treatments are biphasic or downward concave (solid symbols in Figure 1 (100mg kg -1) , and/or hyperthermia (60 min at 41 .50C). FSa-II tumours pretreated with 100mg kg-1 CY responded poorly to the second CY dose given with a treatment interval greater than 4h (Figure 2 , upper panel, solid line). This suggests that drug resistance developed following the first CY administration. The treatment interval of 4h resulted in a marginally longer TG time compared to the single dose, but the difference was not significant. Drug resistance also developed following combined CY and hyperthermia. The development was similar to that following treatment with CY alone (Figure 2, top panel, dotted line) . The tumours pretreated with hyperthermia became slightly resistant to a subsequent administration of CY, but the difference was not statistically significant (Figure 2 , lower panel, solid line). It should be noted that this hyperthermia dose of 41.5°C for 60 min alone did not prolong the TG time of the 4mm FSa-II tumour, and hyperthermia given immediately before CY administration did not enhance the cytotoxic effect of CY. No significant drug resistance was observed when hyperthermia alone was followed by combined CY and heat treatments (Figure 2, lower cyclophosphamide, the effect of preadministration of effect of CY given immediately before heat was enhanced by )phosphamide on the thermal response of the FSa-II hyperthermia and the TG time was prolonged to 25.5 days.
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